Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.
Urrutia S, Kantarjian HM, Ravandi-Kashani F, Bueso-Ramos C, Kanagal-Shamanna R, Jabbour E, Montalban-Bravo G, Short NJ, Daver N, Borthakur G, Dinardo CD, Kadia TM, Masarova L, Bose P, Pemmaraju N, Garcia-Manero G, Sasaki K. Urrutia S, et al. Among authors: kanagal shamanna r. J Hematol Oncol. 2024 Nov 15;17(1):112. doi: 10.1186/s13045-024-01630-w. J Hematol Oncol. 2024. PMID: 39548557 Free PMC article.
Causes of death in patients with myelodysplastic syndrome and spliceosome mutations.
Kontoyiannis PD, Peddireddy AS, Sasaki K, Chien K, Senapati J, Montalban-Bravo G, DiNardo C, Borthakur G, Kanagal-Shamanna R, Bueso-Ramos C, Pierce S, Kantarjian H, Garcia-Manero G, Urrutia S. Kontoyiannis PD, et al. Among authors: kanagal shamanna r. Leuk Res. 2024 Dec;147:107612. doi: 10.1016/j.leukres.2024.107612. Epub 2024 Nov 6. Leuk Res. 2024. PMID: 39536685 No abstract available.
Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
Zhang S, Jiang VC, Han G, Hao D, Lian J, Liu Y, Cai Q, Zhang R, McIntosh J, Wang R, Dang M, Dai E, Wang Y, Santos D, Badillo M, Leeming A, Chen Z, Hartig K, Bigcal J, Zhou J, Kanagal-Shamanna R, Ok CY, Lee H, Steiner RE, Zhang J, Song X, Nair R, Ahmed S, Rodriquez A, Thirumurthi S, Jain P, Wagner-Bartak N, Hill H, Nomie K, Flowers C, Futreal A, Wang L, Wang M. Zhang S, et al. Among authors: kanagal shamanna r. Nat Commun. 2024 Oct 7;15(1):8668. doi: 10.1038/s41467-024-52013-1. Nat Commun. 2024. PMID: 39375332 Free PMC article. No abstract available.
Downregulation of UBA1 expression in myelodysplastic neoplasm.
Wei Y, Zheng H, Li Z, Lockyer PP, Darbaniyan F, Kanagal-Shamanna R, Yang H, Hammond D, Garcia-Manero G. Wei Y, et al. Among authors: kanagal shamanna r. Leukemia. 2024 Oct;38(10):2284-2288. doi: 10.1038/s41375-024-02364-x. Epub 2024 Aug 23. Leukemia. 2024. PMID: 39179668 Free PMC article. No abstract available.
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL.
Kantarjian H, Short NJ, Haddad FG, Jain N, Huang X, Montalban-Bravo G, Kanagal-Shamanna R, Kadia TM, Daver N, Chien K, Alvarado Y, Garcia-Manero G, Issa GC, Garris R, Nasnas C, Nasr L, Ravandi F, Jabbour E. Kantarjian H, et al. Among authors: kanagal shamanna r. J Clin Oncol. 2024 Jul 19:JCO2400272. doi: 10.1200/JCO.24.00272. Online ahead of print. J Clin Oncol. 2024. PMID: 39028925
ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.
Csizmar CM, Gurney M, Kanagal-Shamanna R, Chien K, Hammond D, Lasho TL, Finke CM, Dean C, Natu A, Mangaonkar AA, Al-Kali A, Gangat N, Tefferi A, Alkhateeb H, Garcia-Manero G, Komrokji RS, Ali NA, Padron E, Montalban-Bravo G, Patnaik MM. Csizmar CM, et al. Among authors: kanagal shamanna r. Haematologica. 2024 Oct 1;109(10):3419-3425. doi: 10.3324/haematol.2024.285410. Haematologica. 2024. PMID: 38899337 Free PMC article. No abstract available.
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage.
Gener-Ricos G, Bataller A, Rodriguez-Sevilla JJ, Chien KS, Quesada AE, Almanza-Huante E, Hammond D, Sasaki K, DiNardo C, Kadia T, Daver N, Borthakur G, Issa GC, Short NJ, Kanagal-Shamanna R, Kantarjian HM, Garcia-Manero G, Montalban-Bravo G. Gener-Ricos G, et al. Among authors: kanagal shamanna r. Cancer. 2024 Oct 15;130(20):3452-3462. doi: 10.1002/cncr.35433. Epub 2024 Jun 19. Cancer. 2024. PMID: 38896064
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia.
Montalban-Bravo G, Thongon N, Rodriguez-Sevilla JJ, Ma F, Ganan-Gomez I, Yang H, Kim YJ, Adema V, Wildeman B, Tanaka T, Darbaniyan F, Al-Atrash G, Dwyer K, Loghavi S, Kanagal-Shamanna R, Song X, Zhang J, Takahashi K, Kantarjian H, Garcia-Manero G, Colla S. Montalban-Bravo G, et al. Among authors: kanagal shamanna r. Cell Rep Med. 2024 Jun 18;5(6):101585. doi: 10.1016/j.xcrm.2024.101585. Epub 2024 May 22. Cell Rep Med. 2024. PMID: 38781960 Free PMC article.
Eosinophilia During Lenalidomide Therapy in Myelodysplastic Syndrome.
Sasaki K, Kantarjian H, Montalban-Bravo G, Hammond D, Jabbour E, Kanagal-Shamanna R, Chien K, Garcia-Manero G. Sasaki K, et al. Among authors: kanagal shamanna r. Clin Lymphoma Myeloma Leuk. 2024 Sep;24(9):629-633. doi: 10.1016/j.clml.2024.04.007. Epub 2024 Apr 18. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38777652
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications.
Abuasab T, Borthakur G, Kanagal-Shamanna R, Masarova L, Patel K, Takahashi K, Bose P, Villarreal J, Pierce S, Kadia T, Garcia-Manero G, Short NJ, DiNardo C, Daver N, Ravandi F, Kantarjian H, Verstovsek S, Yilmaz M. Abuasab T, et al. Among authors: kanagal shamanna r. Am J Hematol. 2024 Jul;99(7):1434-1436. doi: 10.1002/ajh.27333. Epub 2024 Apr 13. Am J Hematol. 2024. PMID: 38613831 No abstract available.
255 results